 | • レポートコード：GIR-107A12630 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、乾癬治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。乾癬治療の種類別市場規模（TNF阻害剤、PDE4阻害剤、インターロイキンブロッカー、その他）、用途別市場規模（経口、非経口、局所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・乾癬治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Astellas Pharma Inc.、AstraZeneca plc、Boehringer Ingelheim GmbH、F. Hofffmann-La Roche、GlaxoSmithKline plc、Merck & Co., Inc.、Valeant Pharmaceuticals International, Inc.、Biocon Limited、Eli Lilly and Company、G & W Laboratories Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：TNF阻害剤、PDE4阻害剤、インターロイキンブロッカー、その他 ・用途別分析2016年-2026年：経口、非経口、局所 ・乾癬治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・乾癬治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・乾癬治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・乾癬治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・乾癬治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Psoriasis Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Psoriasis Therapeutics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Psoriasis Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Psoriasis Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Others
Market segment by Application, can be divided into
Oral
Parenteral
Topical
Market segment by players, this report covers
Astellas Pharma Inc.
AstraZeneca plc
Boehringer Ingelheim GmbH
F. Hofffmann-La Roche
GlaxoSmithKline plc
Merck & Co., Inc.
Valeant Pharmaceuticals International, Inc.
Biocon Limited
Eli Lilly and Company
G & W Laboratories Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Psoriasis Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Psoriasis Therapeutics, with revenue, gross margin and global market share of Psoriasis Therapeutics from 2019 to 2021.
Chapter 3, the Psoriasis Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Psoriasis Therapeutics market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Psoriasis Therapeutics research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Psoriasis Therapeutics
1.2 Classification of Psoriasis Therapeutics by Type
1.2.1 Overview: Global Psoriasis Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Psoriasis Therapeutics Revenue Market Share by Type in 2020
1.2.3 TNF Inhibitors
1.2.4 PDE4 Inhibitors
1.2.5 Interleukin Blockers
1.2.6 Others
1.3 Global Psoriasis Therapeutics Market by Application
1.3.1 Overview: Global Psoriasis Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Oral
1.3.3 Parenteral
1.3.4 Topical
1.4 Global Psoriasis Therapeutics Market Size & Forecast
1.5 Global Psoriasis Therapeutics Market Size and Forecast by Region
1.5.1 Global Psoriasis Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Psoriasis Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Psoriasis Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Psoriasis Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Psoriasis Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Psoriasis Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Psoriasis Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Psoriasis Therapeutics Market Drivers
1.6.2 Psoriasis Therapeutics Market Restraints
1.6.3 Psoriasis Therapeutics Trends Analysis
2 Company Profiles
2.1 Astellas Pharma Inc.
2.1.1 Astellas Pharma Inc. Details
2.1.2 Astellas Pharma Inc. Major Business
2.1.3 Astellas Pharma Inc. Psoriasis Therapeutics Product and Solutions
2.1.4 Astellas Pharma Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Astellas Pharma Inc. Recent Developments and Future Plans
2.2 AstraZeneca plc
2.2.1 AstraZeneca plc Details
2.2.2 AstraZeneca plc Major Business
2.2.3 AstraZeneca plc Psoriasis Therapeutics Product and Solutions
2.2.4 AstraZeneca plc Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 AstraZeneca plc Recent Developments and Future Plans
2.3 Boehringer Ingelheim GmbH
2.3.1 Boehringer Ingelheim GmbH Details
2.3.2 Boehringer Ingelheim GmbH Major Business
2.3.3 Boehringer Ingelheim GmbH Psoriasis Therapeutics Product and Solutions
2.3.4 Boehringer Ingelheim GmbH Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Boehringer Ingelheim GmbH Recent Developments and Future Plans
2.4 F. Hofffmann-La Roche
2.4.1 F. Hofffmann-La Roche Details
2.4.2 F. Hofffmann-La Roche Major Business
2.4.3 F. Hofffmann-La Roche Psoriasis Therapeutics Product and Solutions
2.4.4 F. Hofffmann-La Roche Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 F. Hofffmann-La Roche Recent Developments and Future Plans
2.5 GlaxoSmithKline plc
2.5.1 GlaxoSmithKline plc Details
2.5.2 GlaxoSmithKline plc Major Business
2.5.3 GlaxoSmithKline plc Psoriasis Therapeutics Product and Solutions
2.5.4 GlaxoSmithKline plc Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 GlaxoSmithKline plc Recent Developments and Future Plans
2.6 Merck & Co., Inc.
2.6.1 Merck & Co., Inc. Details
2.6.2 Merck & Co., Inc. Major Business
2.6.3 Merck & Co., Inc. Psoriasis Therapeutics Product and Solutions
2.6.4 Merck & Co., Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Merck & Co., Inc. Recent Developments and Future Plans
2.7 Valeant Pharmaceuticals International, Inc.
2.7.1 Valeant Pharmaceuticals International, Inc. Details
2.7.2 Valeant Pharmaceuticals International, Inc. Major Business
2.7.3 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Product and Solutions
2.7.4 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Valeant Pharmaceuticals International, Inc. Recent Developments and Future Plans
2.8 Biocon Limited
2.8.1 Biocon Limited Details
2.8.2 Biocon Limited Major Business
2.8.3 Biocon Limited Psoriasis Therapeutics Product and Solutions
2.8.4 Biocon Limited Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Biocon Limited Recent Developments and Future Plans
2.9 Eli Lilly and Company
2.9.1 Eli Lilly and Company Details
2.9.2 Eli Lilly and Company Major Business
2.9.3 Eli Lilly and Company Psoriasis Therapeutics Product and Solutions
2.9.4 Eli Lilly and Company Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Eli Lilly and Company Recent Developments and Future Plans
2.10 G & W Laboratories Inc.
2.10.1 G & W Laboratories Inc. Details
2.10.2 G & W Laboratories Inc. Major Business
2.10.3 G & W Laboratories Inc. Psoriasis Therapeutics Product and Solutions
2.10.4 G & W Laboratories Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 G & W Laboratories Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Psoriasis Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Psoriasis Therapeutics Players Market Share
3.2.2 Top 10 Psoriasis Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Psoriasis Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Psoriasis Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Psoriasis Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Psoriasis Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Psoriasis Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Psoriasis Therapeutics Revenue by Type (2016-2026)
6.2 North America Psoriasis Therapeutics Revenue by Application (2016-2026)
6.3 North America Psoriasis Therapeutics Market Size by Country
6.3.1 North America Psoriasis Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Psoriasis Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Psoriasis Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Psoriasis Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Psoriasis Therapeutics Revenue by Type (2016-2026)
7.2 Europe Psoriasis Therapeutics Revenue by Application (2016-2026)
7.3 Europe Psoriasis Therapeutics Market Size by Country
7.3.1 Europe Psoriasis Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Psoriasis Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Psoriasis Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Psoriasis Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Psoriasis Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Psoriasis Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Psoriasis Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Psoriasis Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Psoriasis Therapeutics Market Size by Region
8.3.1 Asia-Pacific Psoriasis Therapeutics Revenue by Region (2016-2026)
8.3.2 China Psoriasis Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Psoriasis Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Psoriasis Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Psoriasis Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Psoriasis Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Psoriasis Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Psoriasis Therapeutics Revenue by Type (2016-2026)
9.2 South America Psoriasis Therapeutics Revenue by Application (2016-2026)
9.3 South America Psoriasis Therapeutics Market Size by Country
9.3.1 South America Psoriasis Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Psoriasis Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Psoriasis Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Psoriasis Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Psoriasis Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Psoriasis Therapeutics Market Size by Country
10.3.1 Middle East & Africa Psoriasis Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Psoriasis Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Psoriasis Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Psoriasis Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Psoriasis Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Psoriasis Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Psoriasis Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Psoriasis Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Psoriasis Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. Astellas Pharma Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Astellas Pharma Inc. Major Business
Table 8. Astellas Pharma Inc. Psoriasis Therapeutics Product and Solutions
Table 9. Astellas Pharma Inc. Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. AstraZeneca plc Corporate Information, Head Office, and Major Competitors
Table 11. AstraZeneca plc Major Business
Table 12. AstraZeneca plc Psoriasis Therapeutics Product and Solutions
Table 13. AstraZeneca plc Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Boehringer Ingelheim GmbH Corporate Information, Head Office, and Major Competitors
Table 15. Boehringer Ingelheim GmbH Major Business
Table 16. Boehringer Ingelheim GmbH Psoriasis Therapeutics Product and Solutions
Table 17. Boehringer Ingelheim GmbH Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. F. Hofffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 19. F. Hofffmann-La Roche Major Business
Table 20. F. Hofffmann-La Roche Psoriasis Therapeutics Product and Solutions
Table 21. F. Hofffmann-La Roche Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. GlaxoSmithKline plc Corporate Information, Head Office, and Major Competitors
Table 23. GlaxoSmithKline plc Major Business
Table 24. GlaxoSmithKline plc Psoriasis Therapeutics Product and Solutions
Table 25. GlaxoSmithKline plc Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Merck & Co., Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Merck & Co., Inc. Major Business
Table 28. Merck & Co., Inc. Psoriasis Therapeutics Product and Solutions
Table 29. Merck & Co., Inc. Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Valeant Pharmaceuticals International, Inc. Corporate Information, Head Office, and Major Competitors
Table 31. Valeant Pharmaceuticals International, Inc. Major Business
Table 32. Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Product and Solutions
Table 33. Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Biocon Limited Corporate Information, Head Office, and Major Competitors
Table 35. Biocon Limited Major Business
Table 36. Biocon Limited Psoriasis Therapeutics Product and Solutions
Table 37. Biocon Limited Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors
Table 39. Eli Lilly and Company Major Business
Table 40. Eli Lilly and Company Psoriasis Therapeutics Product and Solutions
Table 41. Eli Lilly and Company Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. G & W Laboratories Inc. Corporate Information, Head Office, and Major Competitors
Table 43. G & W Laboratories Inc. Major Business
Table 44. G & W Laboratories Inc. Psoriasis Therapeutics Product and Solutions
Table 45. G & W Laboratories Inc. Psoriasis Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Psoriasis Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 47. Global Psoriasis Therapeutics Revenue Share by Players (2019-2021)
Table 48. Breakdown of Psoriasis Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Psoriasis Therapeutics Players Head Office, Products and Services Provided
Table 50. Psoriasis Therapeutics Mergers & Acquisitions in the Past Five Years
Table 51. Psoriasis Therapeutics New Entrants and Expansion Plans
Table 52. Global Psoriasis Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 53. Global Psoriasis Therapeutics Revenue Share by Type (2016-2021)
Table 54. Global Psoriasis Therapeutics Revenue Forecast by Type (2021-2026)
Table 55. Global Psoriasis Therapeutics Revenue by Application (2016-2021)
Table 56. Global Psoriasis Therapeutics Revenue Forecast by Application (2021-2026)
Table 57. North America Psoriasis Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Psoriasis Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Psoriasis Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Psoriasis Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Psoriasis Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Psoriasis Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Psoriasis Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Psoriasis Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Psoriasis Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Psoriasis Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Psoriasis Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Psoriasis Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Psoriasis Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Psoriasis Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Psoriasis Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Psoriasis Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Psoriasis Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Psoriasis Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Psoriasis Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Psoriasis Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Psoriasis Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Psoriasis Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Psoriasis Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Psoriasis Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Psoriasis Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Psoriasis Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Psoriasis Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Psoriasis Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Psoriasis Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Psoriasis Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Psoriasis Therapeutics Picture
Figure 2. Global Psoriasis Therapeutics Revenue Market Share by Type in 2020
Figure 3. TNF Inhibitors
Figure 4. PDE4 Inhibitors
Figure 5. Interleukin Blockers
Figure 6. Others
Figure 7. Psoriasis Therapeutics Revenue Market Share by Application in 2020
Figure 8. Oral Picture
Figure 9. Parenteral Picture
Figure 10. Topical Picture
Figure 11. Global Psoriasis Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Psoriasis Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Psoriasis Therapeutics Revenue Market Share by Region (2016-2026)
Figure 14. Global Psoriasis Therapeutics Revenue Market Share by Region in 2020
Figure 15. North America Psoriasis Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Psoriasis Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Psoriasis Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Psoriasis Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Psoriasis Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Psoriasis Therapeutics Market Drivers
Figure 21. Psoriasis Therapeutics Market Restraints
Figure 22. Psoriasis Therapeutics Market Trends
Figure 23. Astellas Pharma Inc. Recent Developments and Future Plans
Figure 24. AstraZeneca plc Recent Developments and Future Plans
Figure 25. Boehringer Ingelheim GmbH Recent Developments and Future Plans
Figure 26. F. Hofffmann-La Roche Recent Developments and Future Plans
Figure 27. GlaxoSmithKline plc Recent Developments and Future Plans
Figure 28. Merck & Co., Inc. Recent Developments and Future Plans
Figure 29. Valeant Pharmaceuticals International, Inc. Recent Developments and Future Plans
Figure 30. Biocon Limited Recent Developments and Future Plans
Figure 31. Eli Lilly and Company Recent Developments and Future Plans
Figure 32. G & W Laboratories Inc. Recent Developments and Future Plans
Figure 33. Global Psoriasis Therapeutics Revenue Share by Players in 2020
Figure 34. Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Psoriasis Therapeutics Revenue Market Share in 2020
Figure 36. Global Top 10 Players Psoriasis Therapeutics Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Psoriasis Therapeutics Revenue Share by Type in 2020
Figure 39. Global Psoriasis Therapeutics Market Share Forecast by Type (2021-2026)
Figure 40. Global Psoriasis Therapeutics Revenue Share by Application in 2020
Figure 41. Global Psoriasis Therapeutics Market Share Forecast by Application (2021-2026)
Figure 42. North America Psoriasis Therapeutics Sales Market Share by Type (2016-2026)
Figure 43. North America Psoriasis Therapeutics Sales Market Share by Application (2016-2026)
Figure 44. North America Psoriasis Therapeutics Revenue Market Share by Country (2016-2026)
Figure 45. United States Psoriasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Psoriasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Psoriasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Psoriasis Therapeutics Sales Market Share by Type (2016-2026)
Figure 49. Europe Psoriasis Therapeutics Sales Market Share by Application (2016-2026)
Figure 50. Europe Psoriasis Therapeutics Revenue Market Share by Country (2016-2026)
Figure 51. Germany Psoriasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Psoriasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Psoriasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Psoriasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Psoriasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Psoriasis Therapeutics Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Psoriasis Therapeutics Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Psoriasis Therapeutics Revenue Market Share by Region (2016-2026)
Figure 59. China Psoriasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Psoriasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Psoriasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Psoriasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Psoriasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Psoriasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Psoriasis Therapeutics Sales Market Share by Type (2016-2026)
Figure 66. South America Psoriasis Therapeutics Sales Market Share by Application (2016-2026)
Figure 67. South America Psoriasis Therapeutics Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Psoriasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Psoriasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Psoriasis Therapeutics Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Psoriasis Therapeutics Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Psoriasis Therapeutics Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Psoriasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Psoriasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Psoriasis Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界のヒト免疫不全ウイルス（HIV）-1治療市場 2021：企業別、地域別、種類・用途別 The Human Immunodeficiency Virus (HIV)-1 Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…- 世界のメルケル細胞癌治療市場 2021：企業別、地域別、種類・用途別 The Merkel Cell Carcinoma Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界の乾癬性関節炎治療薬市場予測（～2024年） Psoriatic arthritis is a chronic autoimmune inflammatory disorder that causes inflammation, swelling, and stiffness at any joint of the body. Psoriatic arthritis is a progressive form of psoriasis, characterized by the itchy, scaly red patches on the skin. Scope of the Report: Asia Pacific is antici…
- 世界のヒト免疫不全ウイルス（HIV）治療市場 2021：企業別、地域別、種類・用途別 The Human Immunodeficiency Virus (HIV) Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 世界の糖鎖生物学（診断・治療）市場 2021：企業別、地域別、種類・用途別 The Glycobiology (Diagnostics and Therapeutics) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…